Abstract:e21062 Background: Pulmonary carcinoids (PCs), comprising of typical carcinoids (TCs) and atypical carcinoids (ACs), are rare low-grade malignant tumors and surgical resection is considered as the standard treatment for early stage PCs. However, it is not clear whether sublobar (Sub-L) resection of PCs would compromise the long-term oncologic outcomes. Here we investigate the equivalency of Sub-L resection versus lobectomy (Lobe) for patients with early stage PCs using the population-based Surveillance, Epidemiology, and End Results (SEER) registry. Methods: The clinical and survival data of early stage PC patients with less or equal 3cm diameter were retrieved. Kaplan-Meier method and log-rank tests were used to assess differences in overall survival (OS). We further performed the subgroup analysis by tumor size (T≤1cm, 1cm < T≤2cm, 2cm < T≤3cm) and patient age ( < 70y and ≥70y). To reduce the bias of inherent retrospective study, we also performed propensity score matching (PSM) analysis by 1:1 fixed ratio nearest neighbor matching using Matchit package in R. Results: In total of 2934 PC patients, including 2741 TCs and 193 ACs, were recruited. 1011(34.46%) and 1923(65.54%) patients received Sub-L resection and lobectomy, respectively. After PSM, there was no significant difference between Sub-L and Lobe group in terms of OS in PC patients (P = 0.33). From the cox regression analysis, it indicated that older age, male gender, larger tumor size, AC histology type and Sub-L surgery were associated with a worse OS. We further performed PSM analysis on TCs and ACs, respectively. For TC patients, it indicated that patients in Lobe group had a much better OS compared to those in Sub-L group (p = 0.0067). In the subgroup analysis, the log-rank tests showed that there was a significant survival advantage for lobectomy in comparison with Sub-L resection for the TC patients with diameter 2cm < T≤3cm (p = 0.0345), but not for those with diameter lower than 2cm. In the subgroup analysis of age, the log-rank test indicated that Lobe group in age < 70 had a better prognosis with statistical difference compared to Sub-L group (p = 0.0032). For ACs, there was no statistic difference between Sub-L and Lobe group after PSM analysis in all the subgroup investigations. Conclusions: Sublobar resection may not significantly compromise the long-term oncologic outcomes in early stage PC patients. However, there is a survival benefit of lobectomy in certain pathological type and population, such as TCs patients with tumor size more than 2cm and age lower than 70-year-old.

Wedge resection is equal to segmental resection for pulmonary typical carcinoid patients at localized stage: a population-based analysis.

Anatomical resections are superior to wedge resections for overall survival in patients with Stage 1 typical carcinoids

Wedge Resection Versus Anatomic Resection For Long-Term Survival Outcomes Of Stage Ia Pulmonary Atypical Carcinoids: A Seer Population-Based Study

Survival Rates after Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.

Survival and Long-Term Cause-Specific Mortality Associated with Stage IA Lung Adenocarcinoma after Wedge Resection Vs. Segmentectomy: A Population-Based Propensity Score Matching and Competing Risk Analysis

Sublobar Resection Versus Lobectomy for Early-Stage Pulmonary Carcinoid Tumors 3 cm in Size A SEER Population-Based Study

A Propensity Score Matching Analysis of Survival Following Segmentectomy or Wedge Resection in Early-Stage Lung Invasive Adenocarcinoma or Squamous Cell Carcinoma

Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis

The Surgical Management of Early-Stage Lung Adenocarcinoma: is Wedge Resection Effective?

Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non‐small cell lung cancers?

STS Database Analysis: Comparing Sublobar Techniques in Stage IA Lung Cancer

Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?

Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis.

Choice of wedge resection for selected T1a/bN0M0 non-small cell lung cancer

Sublobar resection versus lobectomy for early-stage pulmonary carcinoid tumors with three centimeters or less in size: A population-based study.

Intentional wedge resection versus segmentectomy for ≤2 cm Ground-Glass-Opacity-Dominant Non-Small cell lung cancer: a Real-World study using inverse probability of treatment weighting

Choice Of Surgical Procedure For Patients With Non-Small-Cell Lung Cancer <= 1 Cm Or > 1 To 2 Cm Among Lobectomy, Segmentectomy, And Wedge Resection: A Population-Based Study

Segmentectomy or lobectomy for early stage lung cancer: a meta-analysis.

Prognostic Factors in Resected Pulmonary Carcinoid Tumors: A Retrospective Study with 10 Years of Follow‑up.

The Efficacy and Safety of Wedge Resection for Peripheral Stage IA Lung Adenocarcinoma: a Real-World Study Based on a Single Center

Choice of surgical procedure - lobectomy, segmentectomy, or wedge resection - for patients with stage T1-2N0M0 small cell lung cancer: A population-based study.